This document discusses potential targets for treating Alzheimer's disease. It describes the current treatments which provide mild benefits but do not slow disease progression. Investigational treatments are targeting earlier stages of disease by modifying amyloid and tau proteins to prevent aggregation and neurotoxicity. Future treatments may be able to slow or stop the disease process by intervening at different stages of pathogenesis.